Details for New Drug Application (NDA): 050429
✉ Email this page to a colleague
NDA 050429 describes RIMACTANE, which is a drug marketed by Oxford Pharms and is included in one NDA. Additional details are available on the RIMACTANE profile page.
The generic ingredient in RIMACTANE is rifampin. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the rifampin profile page.
The generic ingredient in RIMACTANE is rifampin. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the rifampin profile page.
Summary for 050429
| Tradename: | RIMACTANE |
| Applicant: | Oxford Pharms |
| Ingredient: | rifampin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050429
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 300MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
